Back to the feed
In brief
On 27.11.2023, a person holding the function "Executive member of the board of directors / senior management" at Addex Therapeutics Ltd disclosed a purchase worth CHF 301’345 to SIX Exchange Regulation.
This is the largest management purchase disclosed at Addex Therapeutics Ltd over the previous 12 months (9 purchases in total).
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A executive member of the board of directors / senior management of Addex Therapeutics Ltd declared a "Purchase" transaction on 27.11.2023.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date27.11.2023
Issuing companyAddex Therapeutics Ltd
ISINCH0029850754
Transaction sidePurchase
Management functionExecutive member of the board of directors / senior management
Security typeRegistered shares
Quantity7’008’033
Unit priceCHF 0.04
AmountCHF 301’345
ConditionsPurchase following the exercise of call options
ExchangeXSWX
Notification IDT1NBR00080
Other Addex Therapeutics Ltd insider transactions
- Purchase · Executive member of the board of directors / senior management27.11.2023CHF 53’760
- Purchase · Executive member of the board of directors / senior management27.11.2023CHF 45’450
- Purchase · Non-executive member of the board of directors27.11.2023CHF 44’856
- Purchase · Non-executive member of the board of directors27.11.2023CHF 24’423
- Purchase · Executive member of the board of directors / senior management27.11.2023CHF 5’487
These figures aggregate public disclosures. They are not investment advice.